{"id":160,"date":"2020-03-05T16:19:06","date_gmt":"2020-03-05T16:19:06","guid":{"rendered":"http:\/\/www.hepbunited.org\/blog\/?p=160"},"modified":"2020-03-05T16:22:56","modified_gmt":"2020-03-05T16:22:56","slug":"improving-diversity-in-clinical-trials-for-hepatitis-b-treatments","status":"publish","type":"post","link":"https:\/\/www.hepbunited.org\/blog\/improving-diversity-in-clinical-trials-for-hepatitis-b-treatments\/","title":{"rendered":"Improving Diversity in Clinical Trials for Hepatitis B Treatments"},"content":{"rendered":"<p>Join Hep B United on <strong>Wednesday, March 11th at 3:00 PM EST<\/strong> for a <a href=\"https:\/\/attendee.gotowebinar.com\/register\/1778539626841775116\" target=\"_blank\" rel=\"noopener\">webinar<\/a> to discuss why representation, including of persons living with hepatitis B, is essential to research, and communication and outreach strategies to improve diversity in clinical trials! Christine Lee, PharmaD, PhD, from the U.S. Food &amp; Drug Administration (FDA) will be providing an overview of clinical trials recruitment and strategies to improve participation and Rhea Racho, MPAff, will discuss the Hepatitis B Foundation&#8217;s participation in the National Institute of Health&#8217;s All of Us Research Program and how the program is working to make medical research more inclusive.<\/p>\n<p>Register <a href=\"https:\/\/attendee.gotowebinar.com\/register\/1778539626841775116\" target=\"_blank\" rel=\"noopener\">here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Join Hep B United on Wednesday, March 11th at 3:00 PM EST for a webinar to discuss why representation, including of persons living with hepatitis B, is essential to research, and communication and outreach strategies to improve diversity in clinical trials! Christine Lee, PharmaD, PhD, from the U.S. Food &amp; Drug Administration (FDA) will be &hellip; <\/p>\n<p><a href=\"https:\/\/www.hepbunited.org\/blog\/improving-diversity-in-clinical-trials-for-hepatitis-b-treatments\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Improving Diversity in Clinical Trials for Hepatitis B Treatments<\/span> &rarr;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[],"_links":{"self":[{"href":"https:\/\/www.hepbunited.org\/blog\/wp-json\/wp\/v2\/posts\/160"}],"collection":[{"href":"https:\/\/www.hepbunited.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hepbunited.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hepbunited.org\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hepbunited.org\/blog\/wp-json\/wp\/v2\/comments?post=160"}],"version-history":[{"count":1,"href":"https:\/\/www.hepbunited.org\/blog\/wp-json\/wp\/v2\/posts\/160\/revisions"}],"predecessor-version":[{"id":161,"href":"https:\/\/www.hepbunited.org\/blog\/wp-json\/wp\/v2\/posts\/160\/revisions\/161"}],"wp:attachment":[{"href":"https:\/\/www.hepbunited.org\/blog\/wp-json\/wp\/v2\/media?parent=160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hepbunited.org\/blog\/wp-json\/wp\/v2\/categories?post=160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hepbunited.org\/blog\/wp-json\/wp\/v2\/tags?post=160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}